Bulletin
Investor Alert

New York Markets After Hours

Illumina Inc.

NAS: ILMN

GO
/marketstate/country/us

After Hours

 --Real time quotes

Feb 1, 2023, 4:53 p.m.

/zigman2/quotes/203509482/composite

$

216.58

Change

+0.06 +0.03%

Volume

Volume 33,193

Real time quotes

/zigman2/quotes/203509482/composite

Today's close

$ 214.20

$ 216.52

Change

+2.32 +1.08%

Day low

Day high

$208.26

$217.64

Open

52 week low

52 week high

$173.45

$371.16

Open

Caroline D. Dorsa

Caroline D. Dorsa founded Institute For Advanced Clinical Trials For Children. Ms. Dorsa is on the board of Biogen, Inc. and 9 other companies.

In her past career she was Chief Financial Officer & Senior Vice President for Gilead Sciences, Inc., Chief Financial Officer & Executive Vice President at Public Service Enterprise Group, Inc. Chief Financial Officer & Executive Vice President of Public Service Electric & Gas Co. Chief Financial Officer of PSEG Energy Holdings LLC, Chief Financial Officer, Director & Executive VP at PSEG Power LLC and Chief Financial Officer & Executive Vice President for PSEG Services Corp. (which are all subsidiaries of Public Service Enterprise Group, Inc.), SVP-Global Human, Health, Strategy & Integration at Merck & Co., Inc. and Chief Financial Officer & Senior Vice President for Avaya, Inc.

She received an undergraduate degree from Colgate University and an MBA from Columbia Business School.

Transactions

Date Shares Transaction Value
05/26/2022 1,232   Award at $0 per share. 0
05/25/2022 352   Derivative/Non-derivative trans. at $242.4 per share. 85,325
06/10/2021 1,000   Disposition at $450 per share. 450,000
05/26/2021 881   Award at $0 per share. 0
05/25/2021 385   Derivative/Non-derivative trans. at $397.09 per share. 152,880
05/27/2020 963   Award at $0 per share. 0
05/26/2020 519   Derivative/Non-derivative trans. at $354.41 per share. 183,939
05/29/2019 1,298   Award at $0 per share. 0
05/23/2019 589   Derivative/Non-derivative trans. at $308.97 per share. 181,984
05/23/2018 1,473   Award at $0 per share. 0
05/22/2018 922   Derivative/Non-derivative trans. at $270.8 per share. 249,678

Officers and Executives

Mr. Francis A. deSouza
President, Chief Executive Officer & Director
Mr. Kevin Pegels
Chief-Global Operations
Dr. Joydeep Goswami
Chief Financial & Strategy Officer
Dr. Alex Aravanis
CTO, Head-Research & Product Development
Ms. Carissa Rollins
Chief Information Officer
Dr. Phillip G. Febbo
Chief Medical Officer
Ms. Susan H. Tousi
Chief Commercial Officer
Dr. Craig Michael Ciesla
Vice President
Dr. Bryan Crane
Vice President & Head-System Design
Mr. Charles E. Dadswell
Secretary & General Counsel
Ms. Paula Lynn Dowdy
SVP & GM-Commercial Operations, Europe
Ms. Kathryne Reeves
Chief Marketing Officer
Mr. Scott Ericksen
Ms. Sallilyn Schwartz
Vice President-Investor Relations
Ms. Aimee Hoyt
Chief People Officer & Senior Vice President
Mr. John Frank
Chief Public Affairs Officer
Dr. John Wendell Thompson
Chairman
Dr. Scott Gottlieb
Independent Director
Dr. Robert S. Epstein
Independent Director
Dr. Frances Hamilton Arnold
Independent Director
Mr. Philip W. Schiller
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Gary S. Guthart
Independent Director
Ms. Susan E. Siegel
Independent Director
Link to MarketWatch's Slice.